The epitopes of the captured antigens presented on human-leukocyte-antigen (HLA) molecules of APCs can initiate the activation and differentiation of tumor-specific CD4+ and CD8+ T cells in the draining lymph node, resulting in the expansion of effector T cells in secondary lymphoid organs [29]. This evidence concerns the gene CD8A and neoplasm.